Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LEF1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | RNF183 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | ZNF177 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | FAM212B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | ZNF250 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | STXBP5L | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | ZNF559 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | GPATCH4 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | DCAF6 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
mRNA | UNC79 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |